XNZE
CBD
Market cap18mUSD
Mar 25, Last price
0.10NZD
Name
Cannasouth Ltd
Chart & Performance
P/E
—
P/S
33.89
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
956k
+579.62%
Net income
-9m
L+7.39%
CFO
-9m
L+72.92%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cannasouth Limited operates as a biopharmaceutical firm within New Zealand, actively engaged in the entire lifecycle of cannabinoid-based pharmaceuticals and raw cannabis materials, from their initial research and development through to manufacturing and distribution. This company was founded in 2018 and maintains its headquarters in Hamilton, New Zealand.
Valuation
Title NZD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | |||||
Cost of revenue | |||||
Unusual Expense (Income) | |||||
NOPBT | |||||
NOPBT Margin | |||||
Operating Taxes | |||||
Tax Rate | |||||
NOPAT | |||||
Net income | |||||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | |||||
| Cash flow | |||||
Cash from operating activities | |||||
CAPEX | |||||
Cash from investing activities | |||||
Cash from financing activities | |||||
FCF | |||||
| Balance | |||||
Cash | |||||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | |||||
Invested Capital | |||||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | |||||
Price | |||||
Market cap | |||||
EV | |||||
EBITDA | |||||
EV/EBITDA | |||||
Interest | |||||
Interest/NOPBT | |||||